G01N 2333/585
Calcitonins
G01N2333/585 (Calcitonins) appears on 53 US grants and 93 published applications in this corpus.
Search patents in G01N- Granted patents
- 53
- Published applications
- 93
- Assignees
- 41
- Inventors
- 176
- Latest grant
- 31 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 2 | 1 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 1 | 4 |
| 2010 | 1 | 3 |
| 2011 | 2 | 9 |
| 2012 | 0 | 5 |
| 2013 | 5 | 6 |
| 2014 | 4 | 4 |
| 2015 | 2 | 7 |
| 2016 | 2 | 5 |
| 2017 | 4 | 6 |
| 2018 | 5 | 3 |
| 2019 | 2 | 10 |
| 2020 | 3 | 2 |
| 2021 | 4 | 8 |
| 2022 | 4 | 2 |
| 2023 | 3 | 5 |
| 2024 | 4 | 7 |
| 2025 | 2 | 2 |
| 2026 | 2 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Detection method using both fluorescence and chemiluminescence labels31 Mar 2026US 12,590,976 B2Access Medical Systems, Ltd.
- Methods for determining the concentration of an analyte in the plasma fraction of a sample of whole blood17 Mar 2026US 12,578,330 B2Gentian AS
- Workflow for risk assessment and patient management using procalcitonin and midregional-proadrenomedullin1 Apr 2025US 12,265,092 B2B.R.A.H.M.S GmbH
- Treatment of severe community acquired pneumonia7 Jan 2025US 12,186,391 B2Biotest AG
- Biomarkers for the diagnosis of invasive fungal infections31 Dec 2024US 12,181,474 B2B.R.A.H.M.S GmbH
- Multi-Analyte Rapid Diagnostic Test for Sepsis Using Novel Biomarkers and Quantum Dot Technology1 Oct 2026US 2026/0298921 A1Trimar Domestic Inc.
- Modified immuno-molecular assay for faster biomarker detection30 Jul 2026US 2026/0218271 A1Biomerieux
- Method for performing early diagnosis of sepsis using analysis device including micro filter7 Aug 2025US 2025/0251397 A1Glory Biotech Corp.
- Improved methods and devices for accurate diagnosis of infections15 May 2025US 2025/0154609 A1Rapid Pathogen Screening, Inc.
- Protein signatures for distinguishing between bacterial and viral infections19 Dec 2024US 2024/0418716 A1MeMed Diagnostics Ltd.
Most cited
By later US patents
- Method for early detection, detection of the severity and for a treatment-accompanying assessment of the course of a sepsis76US 5,639,617 AB.R.A.H.M.S. Diagnostica GmbH · 1997
- Method and substances for diagnosis and therapy of sepsis and sepsis-like systemic infections63US 6,756,483 B1B.R.A.H.M.S GmbH · 2004
- Antibodies for the selective determination of procalcitonin 1-11619US 8,354,506 B2B.R.A.H.M.S GmbH · 2013
- Marker for graft failure and mortality15US 8,889,366 B2B.R.A.H.M.S GmbH · 2014
- Method for determining sepsis using pro-ANF14US 7,498,139 B2B.R.A.H.M.S GmbH · 2009